Robert J. Chisholm, MD, FRCPC

Bailout Use of Platelet Glycoprotein IIb/IIIa Inhibition During Coronary Stent Implantation: Observations from the ESPRIT Trial

08/01/2008

James E. Tcheng , MD;

Michael M. Kitt , MD;

David J. Cohen , MD, MPH, MSc;

Robert J. Chisholm , MD, FRCPC;

Henry K. Lui , MD;

Robert L. Feldman , MD;

Robert Green , MD;

Anne S. Hellkamp , PhD;

Warren J. Cantor , MD;

J. Conor O'Shea , MD;

Mina Madan , MD, MPH;

Potent inhibition of platelet aggregation during percutaneous coronary intervention (PCI) using intravenous antagonists of the platelet glycoprotein (GP) IIb/IIIa receptor results in a significant and sustained reduction in the occurrence of...

Potent inhibition of platelet...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Comparison of Abciximab and Eptifibatide on Angiographic and Clinical Outcomes in (FULL TITLE BELOW)

08/05/2010

Affan Irfan , MBBS;

Jo-Ann Christie , BSc;

Michael J.B. Kutryk , MD, PhD;

Robert J. Chisholm , MD, FRCPC;

Asim N. Cheema , MD, PhD;

Alan J. Bagnall , MBChB, PhD;

Atif Mohammad , MD;

Tony Hong , BSc;

Waseem Sharieff , MD, PhD;

Ravi R. Bajaj , MD;

NULL

08/05/2010

Journal of Invasive Cardiology

Review

Post-Traumatic Ventricular Septal Defects ‚Äî Review of the Literature and a Novel Technique for Percutaneous Closure

09/01/2009

Robert J. Chisholm , MD, FRCPC;

Asim N. Cheema , MD, PhD;

Reda Ibrahim , MD;

Nicholas J. Collins , BMed, FRACP, MD;

Payam Dehghani , MD, FRCPC;

David Latter , MD;

ABSTRACT: Post-traumatic ventricular septal defect (VSD) is infrequent, with clinical sequelae ranging from imminent death to complete spontaneous resolution. The most appropriate management strategy is unclear. Careful observation has been...

ABSTRACT: Post-traumatic...

09/01/2009

Journal of Invasive Cardiology